[EN] PROLYL HYDROXYLASE INHIBITORS<br/>[FR] INHIBITEURS DE PROLYL HYDROXYLASES
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2009158315A1
公开(公告)日:2009-12-30
The invention described herein relates to certain pyrimidinedione N-substituted glycine derivatives of formula (I) (formula should be inserted here) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
The present disclosure discloses a modified compound of andrographolide, and particularly discloses a compound shown in formula (I) and (II) or a pharmaceutically acceptable salt thereof.
本公开披露了穿心莲内酯的改良化合物,特别是披露了式 (I) 和 (II) 所示的化合物或其药学上可接受的盐。
2-OXOPYRIDIN-3-YL THIA(DI)AZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES
申请人:AMGEN INC.
公开号:EP1575947A1
公开(公告)日:2005-09-21
EP1828135A4
申请人:——
公开号:EP1828135A4
公开(公告)日:2009-08-12
COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROIDAL RECEPTORS AND CALCIUM CHANNEL ACTIVITIES